January 2018 P & T Updates

Similar documents
May 2017 P&T Updates

November 2018 P & T Updates

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

Losartan lisinopril equivalent dose

2018 Step Therapy Criteria

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

Lisinopril 20 converting to losartan

Conversion of losartan to lisinopril

March 2017 P&T Updates

Lisinopril losartan conversion dose

Lisinopril to losartan equivalent

Step Therapy Criteria 2019

Florida Blue QUALITY PERFORMANCE METRIC STANDARDS FEBRUARY 2013

July 2017 P&T Updates

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

ELEVATE. Formulary Updates to Elevate Plans (Bronze HDHP/Standard, Silver Select/Standard & Gold Select/Standard)

Losartan lisinopril equivalent dose 新着 news 2018 年 3 月 6 日高等部 3 年生 大阪リゾート & スポーツ専門学校に合格! 2018 年 3 月 2 日茨木市立山手台小学校との交流.

Entresto (Sacubitril Valsartan) An information guide

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

Instructions and Checklist for Your Heart Procedure

PPHP 2017 Formulary 2017 Step Therapy Criteria

Guide to the Modernized Reference Drug Program

Drug Formulary. A healthier you. A healthier community.

HEALTHCARE EFFECTIVENESS DATA AND INFORMATION SET (HEDIS )

Select Preventive Prescription Drugs Jan. 1, 2018

March 2018 P & T Updates

Neighborhood Medicaid Formulary Changes: June 2017

2013 Step Therapy (ST) Criteria

DIFICID. Products Affected Step 2: DIFICID TABLET 200 MG ORAL. Details

May 2016 P & T Updates

2018 CareOregon Advantage Part D Formulary Changes

Guidelines for the Prescribing of Sacubitril / Valsartan

ASEBP and ARTA TARP Drugs and Reference Price by Categories

DRUG CLASSIFICATION. Prevention of Cardiovascular Disease

Clinical Policy: ACEI and ARB Duplicate Therapy Reference Number: CP.PMN.61 Effective Date: Last Review Date: 05.18

Health Partners Medicare Prime 2019 Formulary Changes

Save on your drugs with HealthyRx

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

Trandolapril to lisinopril

Medications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy

Entresto Development of sacubitril/valsartan (LCZ696) for the treatment of heart failure with reduced ejection fraction

Is there a need for renal computerised clinical decision support in a university hospital setting?

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

Factors Involved in Poor Control of Risk Factors

Medicare Shared Savings Program Accountable Care Organization (ACO) Measures Deep Dive Series

Scientific conclusions and detailed explanation of the scientific grounds for the differences from the PRAC recommendation

ACE Inhibitors and ARBs To Protect Your Heart? A Guide for Patients Being Treated for Stable Coronary Heart Disease

Are Specialty Pharmacy Drugs Worth the Cost? How Companies Can Make Them More Affordable.

Scientific conclusions and detailed explanation of the scientific grounds for the differences from the PRAC recommendation

Generic Preventive Care/ Safe Harbor Drug Program List

Medications for Type 2 Diabetes CDE Exam Preparation

Alaska Medicaid 90 Day** Generic Prescription Medication List

2018 Formulary Update

Annual Review of Antihypertensives - Fiscal Year 2009

Generics. Lead with. Prescription Step Therapy Program

Cardiac Medications At A Glance

March 2017 Pharmacy & Therapeutics Committee Decisions

Step Therapy Requirements. Effective: 11/01/2018

Commercial Formulary and Utilization Management Program Updates for January 2017 Producer Communication #782 Issued November 10, 2016

CARE N CARE HEALTH PLAN

Pharmacy and Therapeutics Update

Ontario Public Drug Programs

Brookings Roundtable on Active Medical Product Surveillance:

Intel Connected Care with Providence 2015 Preventive Drug List

Clinical Teach-Back Cards

$0 Preferred Generics List

Spring How will that pipeline drug impact my benefit plan?

Biologic Immunomodulators Prior Authorization with Quantity Limit Program Summary

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Generic Drugs: What does equal really mean? Dr. Peter J. Lin Director Primary Care Initiatives Canadian Heart Research Centre

Drugs That Require Step Therapy (ST) Step Therapy Medications

NOTIFICATION OF FORMULARY CHANGES

Formulary (Drug List)

Cilazapril to lisinopril dose conversion

FlexRx 6-Tier. SM Pharmacy Benefit Guide

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

2018 Formulary Update

HMO and PPO Formulary Updates November Commercial Results

Step Therapy Requirements. Effective: 05/01/2018

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

Alternative to lisinopril due to cough

QTY LIMIT COPAY (30 DAY/90 DAY) BENIGN PROSTATIC HYPERPLASIA FINASTERIDE $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8

DRUG TREND REPORT. WellDyneRx ANNUAL 1 2% 34% WellDyneRx. Diabetes MS Oncology Asthma/COPD HIV. Pain/inflammation. High Blood Choles Attention Disorde

Matching, Fill in the Blank, Multiple Choice (1 point each)

Ambetter 90-Day-Supply Maintenance Drug List

Drug Regimen Optimization

FirstCarolinaCare Insurance Company. Step Therapy Requirements

Step Therapy Approval Criteria

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

As It Relates to You

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

Amlodipine/olmesartan (Azor ) is indicated for the treatment of hypertension, alone or in combination with other antihypertensive medications.

Transcription:

January 2018 P & T Updates Commercial Triple Tier 4th Tier Applicable Traditional BEVYXXA 3 No 2 BOSULIF 3 2 * Indicates prior authorization (PA) or step (ST) Depending on your specific benefits and in which state you reside, some drugs on this list may have no cost sharing. Detailed s Onetime 42 day fill, 1 tablet 100 mg tablet: 3 tablets, 30 400 mg & 500 mg tablet: 1 tablet per day, 30 day supply Alternatives enoxaparin, fondaparinux, heparin CALQUENCE 3 2 2 capsules, 30 No 1 tablet ELIQUIS 2 No 2 No 2.5 mg tablet: 2 tablets 5 mg tablet: 4 tablets allopurinol, probenecid, Uloric* warfarin, Xarelto, ENTRESTO 2 No 2 2 tablets benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril, quinapril, trandolapril, ramipril, losartan, irbesartan, valsartan NITYR 3 2 No No No Nityr* OZEMPIC 2 No 2 PRADAXA 3 No 2 0.25 mg/0.5 mg Pen: 0.06 ml 1 mg Pen: 0.11 ml 2 capsules warfarin, Eliquis*, Xarelto* SUTENT 3 2 TANZEUM 2 No 2, new No 1 capsule, 28 0.143 ml Initial: 1 ml per 28 days Maintenance: 1 ml per 56 days metformin, Ozempic*, Victoza* sulfasalazine, Enbrel*, Humira*

Commercial (cont.) Triple Tier 4th Tier Applicable Traditional XARELTO 2 No 2 No Detailed s 10 mg & 20 mg tablet: 1 tablet per day 15 mg tablet: 2 tablets Alternatives warfarin, Eliquis, * Shingrix is now available for $0 cost sharing when administered at a pharmacy or at your physicians office. Coverage is limited to one course of (2 vaccines) per lifetime for members greater than or equal to 50 years of age. * Starting April 1, 2018, all prescriptions for adults for a total morphine equivalent dose (MED) of 90 119 will require prior authorization from GHP or an override from the dispensing pharmacist. All prescriptions for a MED of 120 or greater will require prior authorization from GHP. CHIP Tier BEVYXXA 2 BOSULIF 10 CALQUENCE 0 Detailed s Onetime 42 day fill, 1 tablet 100 mg tablet: 3 tablets per day, 30 400 mg & 500 mg tablet: 1 tablet, 30 day supply 2 capsules, 30 day * Indicates prior authorization (PA) or step (ST) Alternatives enoxaparin, fondaparinux, heparin 1 tablet allopurinol, probenecid, Uloric* ELIQUIS 2 No 2.5 mg tablet: 2 tablets 5 mg tablet: 4 tablets warfarin, Xarelto, ENTRESTO 2 2 tablets benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril, quinapril, trandolapril, ramipril, losartan, irbesartan, valsartan NITYR 2 No No Nityr* OZEMPIC 2 PRADAXA 2 SUTENT 0 TANZEUM 2, new 0.25 mg/0.5 mg Pen: 0.06 ml 1 mg Pen: 0.11 ml 2 capsules warfarin, Eliquis*, Xarelto* 1 capsule, 28 day 0.143 ml metformin, Ozempic*, Victoza* Initial: 1 ml per 28 days Maintenance: 1 ml per 56 days Enbrel*, Humira* XARELTO 2 No 10 mg & 20 mg tablet: 1 tablet 15 mg tablet: 2 tablets warfarin, Eliquis,

GHP Family GHP Family Tier Detailed s Alternative(s) BEVYXXA Brand 1 tablet daily Enoxaparin, Fondaparinux, Heparin, Xarelto, Eliquis, CALQUENCE Brand 2 capsules daily 1 tablet daily allopurinol, probenecid ELIQUIS Brand No 2.5 mg: 2 tablets daily, 5 mg: 4 tablets warfarin, Xarelto daily NITYR Brand No No Nityr OZEMPIC Brand No 0.25 mg 0.5 mg: 1.5 ml per 28 days, 1 mg: 3 ml per 28 days PENTAZOCINE 50 MG / NALOXONE 0.5 MG Generic No 3 tablets daily buprenorphine patch PRADAXA Brand 2 capsules daily warfarin, Eliquis, Xarelto TANZEUM Brand (new metformin, Ozempic*, 4 pens per 28 days Victoza* ) XARELTO Brand No 1 syringe per 56 days * Indicates prior authorization (PA) or step (ST) 10 mg, 20 mg: 1 tablet daily, 15 mg: 2 tablets daily Enbrel*, Humira*, Stelara* warfarin, Eliquis

Geisinger Gold * Indicates prior authorization (PA) or step (ST) BEVYXXA $0 Deductible Brand CALQUENCE Specialty Brand MYLOTARG Specialty OZEMPIC RENFLEXIS Brand RITUXAN HYCELA Specialty VYXEOS Specialty Standard Detailed s 1 tablet ; 42 day supply max limit 120 capsules per 30 days 1 tablet Alternative(s) enoxaparin, fondaparinux, heparin Imbruvica*, Velcade*, Revlimid* allopurinol, probenecid, Uloric*, Zurampic* daunorubicin, cytarabine 0.25 mg syr: 1.5 ml every 28 day; 1 mg syr: 3 ml every 28 days 1400 mg vial: 4 vials per 28 days; 1600 mg vial 1 vial per 28 days, Tanzeum* sulfasalazine, Humira*. Enbrel*, Orencia* Rituxan* sulfasalazine, Humira*, Enbrel*, Stelara* daunorubicin, cytarabine

Marketplace Tier BEVYXXA 4 BOSULIF 0 CALQUENCE 0 Detailed s Onetime 42 day fill, 1 tablet 100 mg tablet: 3 tablets, 30 day supply 400 mg & 500 mg tablet: 1 tablet, 30 day 2 capsules, 30 Alternatives enoxaparin, fondaparinux, heparin 1 tablet allopurinol, probenecid, Uloric* ELIQUIS 3 No 2.5 mg tablet: 2 tablets 5 mg tablet: 4 tablets warfarin, Xarelto, ENTRESTO 3 2 tablets benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril, quinapril, trandolapril, ramipril, losartan, irbesartan, valsartan NITYR 5 No No Nityr* OZEMPIC 3 PRADAXA 4 SUTENT 0 TANZEUM 3, new XARELTO 3 No 0.25 mg/0.5 mg Pen: 0.06 ml 1 mg Pen: 0.11 ml per day 2 capsules warfarin, Eliquis*, Xarelto* 1 capsule, 28 0.143 ml metformin, Ozempic*, Victoza* Initial: 1 ml per 28 days Maintenance: 1 ml per 56 days 10 mg & 20 mg tablet: 1 tablet 15 mg tablet: 2 tablets * Indicates prior authorization (PA) or step (ST) Enbrel*, Humira* warfarin, Eliquis, * Shingrix is now available for $0 cost sharing when administered at a pharmacy or at your physicians office. Coverage is limited to one course of (2 vaccines) per lifetime for members greater than or equal to 50 years of age. * Starting April 1, 2018, all prescriptions for adults for a total morphine equivalent dose (MED) of 90 119 will require prior authorization from GHP or an override from the dispensing pharmacist. All prescriptions for a MED of 120 or greater will require prior authorization from GHP.